Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7037952rdf:typepubmed:Citationlld:pubmed
pubmed-article:7037952lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:7037952lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7037952lifeskim:mentionsumls-concept:C0038402lld:lifeskim
pubmed-article:7037952lifeskim:mentionsumls-concept:C1817908lld:lifeskim
pubmed-article:7037952lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:7037952lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:7037952pubmed:issue4lld:pubmed
pubmed-article:7037952pubmed:dateCreated1982-5-21lld:pubmed
pubmed-article:7037952pubmed:abstractTextThe human mononuclear cell response to purified extracellular streptococcal protein, blastogen A, was compared to the response of these cells to PHA and tetanus antigen. Blastogen A induced peak uptake of thymidine during day 6 of tissue culture whereas PHA induced peak uptake during day 5 and tetanus during day 8. Like PHA, blastogen A transformed human umbilical cord lymphocytes and those of nonimmune animals. Also like PHA, blastogen A transformed primarily T lymphocytes. However, unlike PHA, the ability of T lymphocytes to respond to blastogen A was almost completely dependent on the presence of viable non-T lymphocytes. Monocytes were not as effective in facilitating the response to blastogen A as they were for PHA. Thus, blastogen A behaves most like a polyclonal T lymphocyte mitogen, although the degree of dependence of the transformation response on the presence of non-T lymphocytes is much greater than that of PHA.lld:pubmed
pubmed-article:7037952pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7037952pubmed:languageenglld:pubmed
pubmed-article:7037952pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7037952pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7037952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7037952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7037952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7037952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7037952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7037952pubmed:statusMEDLINElld:pubmed
pubmed-article:7037952pubmed:monthAprlld:pubmed
pubmed-article:7037952pubmed:issn0022-1767lld:pubmed
pubmed-article:7037952pubmed:authorpubmed-author:FLUXCClld:pubmed
pubmed-article:7037952pubmed:authorpubmed-author:WannamakerL...lld:pubmed
pubmed-article:7037952pubmed:authorpubmed-author:RegelmannW...lld:pubmed
pubmed-article:7037952pubmed:issnTypePrintlld:pubmed
pubmed-article:7037952pubmed:volume128lld:pubmed
pubmed-article:7037952pubmed:ownerNLMlld:pubmed
pubmed-article:7037952pubmed:authorsCompleteYlld:pubmed
pubmed-article:7037952pubmed:pagination1631-6lld:pubmed
pubmed-article:7037952pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:meshHeadingpubmed-meshheading:7037952-...lld:pubmed
pubmed-article:7037952pubmed:year1982lld:pubmed
pubmed-article:7037952pubmed:articleTitleCharacterization of the human cellular immune response to purified group A streptococcal blastogen A1.lld:pubmed
pubmed-article:7037952pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7037952pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7037952pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7037952lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7037952lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7037952lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7037952lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7037952lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7037952lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7037952lld:pubmed